Page 105 - GTM-4-1
P. 105

Global Translational Medicine                                  Comparative study of Schisandra species on VCI




            A

































                 B                      C                    D                        E










            Figure 5. Comparative effects of SCF and SSF on white matter integrity following BCAS surgery. (A) LFB-stained images showing increased myelin
            rarefaction and white matter lesion formation in the Cc (paramedian), fimbria of the hippocampus (Fi), ventral posteromedial thalamic nucleus (VPT),
            and Cpu (striatum) of BCAS mice, with a visible protective effect in the SCF- and SSF- treated groups. All images were taken under identical exposures and
            conditions (Scale bar: 200 μm; magnification: 20×). (B-E) Quantification analysis of LFB-staining in Cc, Fi, VPT, and Cpu, respectively. Data are presented
            as mean ± SEM (n = 3 per group). Notes: *P < 0.05 and **P < 0.01, compared with the BCAS group (MOD); P < 0.05 and  P < 0.01, compared with the
                                                                                  #
                                                                                          ##
            control group (CON).
            Abbreviations: POS: Positive control; SCF: Schisandra chinensis; SSF: Schisandra sphenanthera; BCAS: Bilateral common carotid artery stenosis; Cc:
            Corpus callosum; Cpu: Caudate putamen.
            lignans, 4 furofurans, 2 lignan lactones), 10 carboxylic   3.7. Pharmacokinetic differences between
            acids (5 eicosanoids, 5 carboxylic acids), 2 lactones, 2   compounds in SCF and SSF
            sesterterpenoids, and 1 pyrrilium (Table S1). For SSF, a   Compounds with high bioavailability and drug-likeness
            total of 63 compounds were identified, including 21 lignans   properties are more likely to be absorbed.  Bioactive compounds
                                                                                            25
            (9 diphenylcyclooctene lignans, 4 dibenzylbutane lignans,   with therapeutic effects are generally expected to exhibit passive
            5 tetrahydrofuran lignans, 2 aryltetralin lignans, 1 furanoid   HIA properties.  Therefore, we further conducted analysis of
                                                                           26
            lignan), 2 terpenoids (1 triterpenoid, 1 sesquiterpenoid),   six physicochemical properties, HIA and BBB permeation, and
            1 lactone, 17 phenylpropanoids (16 phenylpropanoids, 1   interactions with P-gp in the identified compounds.
            flavonoid), 1 phenol, 16 alkaloids, 4 carboxylic acids, and   As shown in Figure 8, the predicted lipophilicity, size,
            1 sulfoxide (Table S2). These results suggest that SCF and   polarity, solubility, flexibility, and saturation properties
            SSF exhibit distinct chemical compositions, which may   were evaluated for the identified compounds. A  total of
            contribute to different pharmacological effects.   64 compounds in  SCF and 60  compounds in  SSF were


            Volume 4 Issue 1 (2025)                         97                              doi: 10.36922/gtm.6879
   100   101   102   103   104   105   106   107   108   109   110